Share

Search your stocks

Ctrl+K

ONYXOnyx Biotec Ltd.

41.4(-0.24%)

1W: -7.68%

1M: -17.00%

1Y: -

Onyx Biotec Quarterly Results

Pros & Cons

POSITIVES

Consistent revenue growth observed over the last four quarters, indicating strong demand in the manufacturing sector.
Improved profit margins in the latest quarter suggest better cost management and operational efficiency.
Strong cash flow generation supports future investments and potential expansion opportunities.

NEGATIVES

Rising raw material costs have impacted profitability despite revenue growth, signaling potential supply chain issues.
Declining sales growth rate in the latest quarter compared to previous ones raises concerns about market saturation.
Increased competition in the manufacturing industry may pressure pricing and market share moving forward.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-